1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porterโs five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitorโs
4.1.4 Threat of New Entrants
5 Middle East and Africa Capsule Market, by product type
5.1 Introduction
5.1.1 Hard Capsules
5.1.2 Soft Capsules
5.1.3 Others
6 Middle East and Africa Capsule Market, by Raw Material
6.1 Introduction
6.1.1 bovine
6.1.2 porcine
6.1.3 non-gelatin
7 Middle East and Africa Capsule Market, by Route of Administration
7.1 Introduction
7.1.1 Oral
7.1.3 Others
8. Middle East and Africa Capsule Market, by end user
8.1 Introduction
8.1.1 Pharmaceuticals
8.1.3 Others
9 Middle East and Africa Capsule Market, by Country
9.1 Introduction
9.2 UAE
9.3 Egypt
9.4 Saudi Arabia
9.5 Kuwait
9.6 Qatar
9.7 Oman
10 Company Landscape
10.1 Introduction
10.1.1 Mergers Acquisitions
10.1.2 Collaborations
10.1.3 Release/New Product Launches
10.1.4 Other (Expansion, Updates, Partnership)
11 Company Profile
11.1 Novartis AG
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financials
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Pfizer, Inc.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Sanofi-Aventis
11.3.1 Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financials
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.4 Merck & Co.
11.4.1 Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financials
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Enzon Pharmaceuticals
11.5.1 Overview
11.5.2 Product/Business Segment Overview
11.5.3 Financials
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Bayer AG
11.6.1 Overview
11.6.2 Product/Business Segment Overview
11.6.3 Financials
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Astellas Pharma
11.7.1 Overview
11.7.2 Product/Business Segment Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7 GlaxoSmithKline plc
11.7.1 Overview
11.7.2 Product/Business Segment Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Abbott
11.8.1 Overview
11.8.2 Product/Business Segment Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Sigma-Aldrich
11.9.1 Overview
11.9.2 Product/Business Segment Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Others
12 Appendix
List of Tables
TABLE 1 MIDDLE EAST AND AFRICA CAPSULE MARKET, 2023-2030 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY PRODUCT TYPE, 2023-2030 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY RAW MATERIAL,2023-2030 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY REGION, 2023-2030 (USD MILLION)
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY PRODUCT TYPE
FIGURE 4 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY RAW MATERIAL
FIGURE 5 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY ROUTE OF ADMINISTRATION
FIGURE 6 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY END USER
FIGURE 7 MIDDLE EAST AND AFRICA CAPSULE MARKET, BY REGION
FIGURE 8 MIDDLE EAST AND AFRICA CAPSULE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)